Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

BACKGROUND: The manufacturing process of a new intravenous immune globulin (IVIG) 10% liquid product incorporates two dedicated pathogen safety steps: solvent/detergent (S/D) treatment and nanofiltration (20 nm). Ion-exchange chromatography (IEC) during protein purification also contributes to patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Radomski, Kai Uwe, Lattner, Georg, Schmidt, Torben, Römisch, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380692/
https://www.ncbi.nlm.nih.gov/pubmed/28236170
http://dx.doi.org/10.1007/s40259-017-0212-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380692/
https://www.ncbi.nlm.nih.gov/pubmed/28236170
http://dx.doi.org/10.1007/s40259-017-0212-y

Ejemplares similares